Plus Therapeutics发布年中业务更新,宣布公司更名

投资观察
Jul 06

Plus Therapeutics Inc. 发布了其2026年年中业务更新,其中包含一项重要的公司品牌重塑计划。该公司宣布,将更名为Cerenome,其纳斯达克股票代码也将于2026年8月3日起变更为CNSY。

与此同时,公司重申了其2026年的关键里程碑指引,这其中包括了其核心诊断产品CNSide的进展。此次更名与业务更新,标志着公司发展进入新阶段。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10